SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 12.10% to Rs. 605.97 millions for the quarter ended June 2022 as compared to Rs. 540.55 millions during the corresponding quarter last year.A big loss of -94.61% reported for the quarter ended June 2022 to Rs. 3.69  millions from Rs. 68.50 millions.Operating profit for the quarter ended June 2022 decreased to 67.31 millions as compared to 100.97 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 605.97 540.55 12.10 605.97 540.55 12.10 2260.97 1879.46 20.30
Other Income 3.13 8.22 -61.92 3.13 8.22 -61.92 33.36 43.93 -24.06
PBIDT 67.31 100.97 -33.34 67.31 100.97 -33.34 291.31 234.72 24.11
Interest 0.14 1.05 -86.67 0.14 1.05 -86.67 2.85 5.14 -44.55
PBDT 9.13 99.92 -90.86 9.13 99.92 -90.86 288.46 229.58 25.65
Depreciation 1.93 2.83 -31.80 1.93 2.83 -31.80 15.26 10.86 40.52
PBT 7.20 97.09 -92.58 7.20 97.09 -92.58 273.20 218.72 24.91
TAX 3.51 28.59 -87.72 3.51 28.59 -87.72 77.32 48.14 60.61
Deferred Tax -4.68 0.13 -3700.00 -4.68 0.13 -3700.00 0.00 0.00 0.00
PAT 3.69 68.50 -94.61 3.69 68.50 -94.61 195.88 170.58 14.83
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 11.11 18.68 -40.53 11.11 18.68 -40.53 12.88 12.49 3.17

Jagsonpal Pharma Share Price

192.80 -0.85 (-0.44%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×